Europe is a “second class continent” for cancer researchBMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7494.746-b (Published 31 March 2005) Cite this as: BMJ 2005;330:746
View Full Text
- Rory Watson
Funding for cancer research in the European Union lags far behind that in the United States and varies enormously from one EU country to another, a new survey by the European Cancer Research Managers Forum shows.
Produced with the support of the European Commission, the survey is the first comprehensive analysis of cancer research funding in Europe. It identified 139 sources of non-commercial financing that provided €1.43bn (£1bn; …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.